Case Study:
Using AI in Precision Identification of Patients With Rare Diseases
AI-Powered Rare Disease Patient Identification and Diagnosis
Rare diseases offer diverse challenges. With Pharma offering rare disease medication, if you can find the patient, they will take your drug; however, finding the patient is the tricky part.
The Client Problem
The client had a rare disease drug with minimal competition.
• The illness is so rare, however, that the main difficulty was finding patients.
• Very few physicians were likely to come in contact with these patients.
• Finding these patients early is critical as the illness progresses.
The Solution
• Certain facial traits were common to sufferers of the condition.
• Eularis created facial recognition software that identified patients with the condition
• It then crawled internet properties, (Facebook and Flickr etc), to find patients from online photos
• This allowed for faster identification and treatment before it was too late for these patients.
• However, due to sensitivity, the identification was addressed in a more palatable way.
• Once patients were identified, targeted advertising of keywords on Google PPC was prepared.
• Therefore, only when a search was conducted on the symptoms by the family, would this be activiated
• This triggered an ad leading them to our client’s website where they could self diagnose
The Outcome
Thirteen new patients were identified very rapidly. At a cost of $500,000/patient/year for the rest of their life, the ROI is undeniable.
To achieve these kinds of results, contact Eularis today.
Latest News
Read our latest blogs here.

The AI Strategy Blind Spot: Why Technical Excellence Isn’t Enough
Artificial intelligence has never been so impressive – or so misunderstood. The world’s smartest engineers have built transformers that read, think, and predict; pipelines now

How to Overcome AI Resistance in Your Organization
In the crucible of modern drug development—where a single molecule’s journey from lab to patient spans an average of 12 years and $2.3 billion—AI has emerged

The Future of AI and Innovation in Pharma in 2026 and Beyond
AI is swiftly reshaping the pharmaceutical industry, transforming every facet from drug discovery to supply chain management with unparalleled speed and precision. The pace of